Patents by Inventor Hazuki Maehata

Hazuki Maehata has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11825856
    Abstract: Provided is a composition for preventing or ameliorating a functional gastrointestinal disorder whose active ingredient is Bifidobacterium breve MCC1274 (FERM BP-11175). A composition for preventing or ameliorating a functional gastrointestinal disorder in the present technology can prevent or improve constipation or frequent bowel movements, regulate the number of bowel movements, improve stool quality, prevent or improve constipation, prevent or ameliorate bloating, or prevent or improve abdominal discomfort. Disclosed is a composition for preventing or ameliorating a functional gastrointestinal disorder accompanied by anxiety disorder. A composition for preventing or ameliorating a functional gastrointestinal disorder in the present technology can be used in a pharmaceutical composition or in a food or beverage composition.
    Type: Grant
    Filed: March 12, 2019
    Date of Patent: November 28, 2023
    Assignee: Morinaga Milk Industry Co., Ltd.
    Inventors: Mai Murata, Junichi Minami, Hazuki Maehata
  • Publication number: 20210000894
    Abstract: An object is to provide an anti-stress composition that can be administered for a long period of time and is highly safe. Provided is an anti-stress composition including Lactobacillus helveticus as an active ingredient. The stress may be mental stress. Furthermore, the composition may be used for treatment or prevention of anxiety disorder, anthropophobia, a decline in sociality, or adjustment disorder. Furthermore, the Lactobacillus helveticus may be Lactobacillus helveticus NITE BP-01671. Furthermore, the composition may be a pharmaceutical composition or a food or drink composition.
    Type: Application
    Filed: March 25, 2019
    Publication date: January 7, 2021
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Yodai Kobayashi, Hazuki Maehata, Tetsuya Kuhara, Atsushi Toyoda
  • Publication number: 20190297909
    Abstract: Provided is a composition for preventing or ameliorating a functional gastrointestinal disorder whose active ingredient is Bifidobacterium breve MCC1274 (FERM BP-11175). A composition for preventing or ameliorating a functional gastrointestinal disorder in the present technology can prevent or improve constipation or frequent bowel movements, regulate the number of bowel movements, improve stool quality, prevent or improve constipation, prevent or ameliorate bloating, or prevent or improve abdominal discomfort. Disclosed is a composition for preventing or ameliorating a functional gastrointestinal disorder accompanied by anxiety disorder. A composition for preventing or ameliorating a functional gastrointestinal disorder in the present technology can be used in a pharmaceutical composition or in a food or beverage composition.
    Type: Application
    Filed: March 12, 2019
    Publication date: October 3, 2019
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Mai Murata, Junichi Minami, Hazuki Maehata
  • Publication number: 20190298783
    Abstract: A composition for relieving stress comprising a Bifidobacterium breve MCC 1274 (FERMBP-11175) as an active ingredient is provided. The composition for relieving stress according to the present technology can improve or prevent stress-induced anger, confusion, tension, or fatigue, or can improve vigor., stress can be assessed by POMS or POMS 2. The composition for relieving stress according to the present technology can be used for pharmaceutical compositions and food and drink compositions.
    Type: Application
    Filed: March 12, 2019
    Publication date: October 3, 2019
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Mai Murata, Junichi Minami, Hazuki Maehata